Plasma ctDNA Tumor Fraction as an Independent Prognostic Factor in Metastatic Colorectal Cancer: Differential Prognostic Impact Across Treatment Lines and Irrespective of Hepatic Metastatic Burden
Plasma ctDNA Tumor Fraction as an Independent Prognostic Factor in Metastatic Colorectal Cancer: Differential Prognostic Impact Across Treatment Lines and Irrespective of Hepatic Metastatic Burden. // The Journal of Liquid Biopsy. – URL: https://www.sciencedirect.com/science/article/pii/S2950195426002389?dgcid=rss_sd_all
Plasma ctDNA Tumor Fraction as an Independent Prognostic Factor in Metastatic Colorectal Cancer: Differential Prognostic Impact Across Treatment Lines and Irrespective of Hepatic Metastatic Burden. The Journal of Liquid Biopsy. https://www.sciencedirect.com/science/article/pii/S2950195426002389?dgcid=rss_sd_all
“Plasma ctDNA Tumor Fraction as an Independent Prognostic Factor in Metastatic Colorectal Cancer: Differential Prognostic Impact Across Treatment Lines and Irrespective of Hepatic Metastatic Burden.” The Journal of Liquid Biopsy.
@article{article68056,
title = {Plasma ctDNA Tumor Fraction as an Independent Prognostic Factor in Metastatic Colorectal Cancer: Differential Prognostic Impact Across Treatment Lines and Irrespective of Hepatic Metastatic Burden},
journal = {The Journal of Liquid Biopsy},
url = {https://www.sciencedirect.com/science/article/pii/S2950195426002389?dgcid=rss_sd_all}
}
Nature Reviews Cancer, Published online: 19 November 2026; doi:10.1038/s41568-026-01001-2 In this Journal Club, Chien-Han Kao and Ruey-Hwa Chen discuss a study showing that tumours use both de novo purine biosynthesis and purine salvage...
npj Precision Oncology, Published online: 19 November 2026; doi:10.1038/s41698-026-01779-2 Targeting SMYD3 in cancer-associated fibroblasts relieves immune suppression and improves anti-PD-L1 response in HPV-negative HNSCC
npj Precision Oncology, Published online: 19 November 2026; doi:10.1038/s41698-026-01786-3 Postoperative timing effects on AI-based resection-cavity segmentation in glioma: multi-site evaluation and relevance assessment